1 September 2017 in Molecular Cell
7 October 2019 in Proceedings of the National Academy of Sciences
Significance: Cancers associated with the human papillomavirus, including oropharyngeal, anal canal, cervical, and vulvar carcinomas, constitute about 4.5% of all solid tumors. In many cases, they can be readily cured with radiotherapy, which is the mainstay of treatment. HPV-associated cancers are more radiosensitive than HPV-negative cancers, but the mechanism of this radiosensitivity is unknown. Across all of oncology, HPV association is one of the only validated molecular biomarker of radiosensitivity. Here, we demonstrate that the HPV16 E7 oncoprotein alters DNA double-strand break repair pathways by promoting error-prone, microhomology-mediated end-joining and suppressing nonhomologous end-joining. These results characterize the molecular mechanism of this unique biomarker in cancer therapy and suggest therapeutic vulnerabilities.
18 September 2020 in ACS Chemical Biology
JCJinnette Tolentino Collado
Jinnette Tolentino Collado
+15
24 December 2021 in Science Advances
This study reveals how pressure drives the morphogenesis of cellular sheets into complex 3D architectures.
13 August 2020 in Communications Biology
Many cell- and tissue-level functions are coordinated by intracellular signaling pathways that trigger the expression of context-specific target genes. Yet the input–output relationships that link pathways to the genes they activate are incompletely understood. Mapping the pathway-decoding logic of natural target genes could also provide a basis for engineering novel signal-decoding circuits. Here we report the construction of synthetic immediate-early genes (SynIEGs), target genes of Erk signaling that implement complex, user-defined regulation and can be monitored by using live-cell biosensors to track their transcription and translation. We demonstrate the power of this approach by confirming Erk duration-sensing by FOS, elucidating how the BTG2 gene is differentially regulated by external stimuli, and designing a synthetic immediate-early gene that selectively responds to the combination of growth factor and DNA damage stimuli. SynIEGs pave the way toward engineering molecular circuits that decode signaling dynamics and combinations across a broad range of cellular contexts.
30 April 2015 in Macromolecules